Tourette Syndrome: Update

Brain and Development

Volumn 37, Issue 7, 2015, Pages 651-655

  Hallett, Mark ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Dopamine; Habit; Inhibition; Sensory habituation; Tic; Urge

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; BOTULINUM TOXIN; CLONIDINE; DOPAMINE; FLUMAZENIL; FLUPHENAZINE; GUANFACINE; HALOPERIDOL; PARVALBUMIN; PIMOZIDE;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ANTERIOR CINGULATE; ATTENTION DEFICIT DISORDER; AUTOSOMAL RECESSIVE INHERITANCE; BEHAVIOR THERAPY; BOLD SIGNAL; BRAIN DEPTH STIMULATION; COGNITION; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GILLES DE LA TOURETTE SYNDROME; HABITUATION; HUMAN; INSULA; OBSESSIVE COMPULSIVE DISORDER; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PERCEPTIVE THRESHOLD; RECOMMENDED DRUG DOSE; REVIEW; SUPERIOR PARIETAL LOBULE; TRANSCRANIAL MAGNETIC STIMULATION; VOXEL BASED MORPHOMETRY; BRAIN; FEMALE; MALE; PSYCHOLOGY; TOURETTE SYNDROME;

BRAIN; FEMALE; HUMANS; MALE; TOURETTE SYNDROME;

EID: 84928667880     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2014.11.005     Document Type: Review

References (41)

1. Freeman R.D. Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome. Eur Child Adolesc Psychiatry 2007, 16(suppl. 1):15-23. Tourette Syndrome International Database Consortium.
2. Bagheri M.M., Kerbeshian J., Burd L. Recognition and management of Tourette's syndrome and tic disorders. Am Fam Physician 1999, 59. 2263-72, 74.
3. Robertson M.M. The Gilles de la Tourette syndrome: the current status. Arch Dis Child Educ Pract Ed 2012, 97:166-175.
4. Kwak C., Dat Vuong K., Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord 2003, 18:1530-1533.
5. Scharf J.M., Yu D., Mathews C.A., Neale B.M., Stewart S.E., Fagerness J.A., et al. Genome-wide association study of Tourette's syndrome. Mol Psychiatry 2013, 18:721-728.
6. Castellan Baldan L., Williams K.A., Gallezot J.D., Pogorelov V., Rapanelli M., Crowley M., et al. Histidine decarboxylase deficiency causes Tourette syndrome: parallel findings in humans and mice. Neuron 2014, 81:77-90.
7. Bloch M.H., Leckman J.F., Zhu H., Peterson B.S. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005, 65:1253-1258.
8. Garraux G., Goldfine A., Bohlhalter S., Lerner A., Hanakawa T., Hallett M. Increased midbrain gray matter in Tourette's syndrome. Ann Neurol 2006, 59:381-385.
9. Ludolph A.G., Juengling F.D., Libal G., Ludolph A.C., Fegert J.M., Kassubek J. Grey-matter abnormalities in boys with Tourette syndrome: magnetic resonance imaging study using optimised voxel-based morphometry. Br J Psychiatry 2006, 188:484-485.
10. Muller-Vahl K.R., Grosskreutz J., Prell T., Kaufmann J., Bodammer N., Peschel T. Tics are caused by alterations in prefrontal areas, thalamus and putamen, while changes in the cingulate gyrus reflect secondary compensatory mechanisms. BMC Neurosci 2014, 15:6.
11. Cheng B., Braass H., Ganos C., Treszl A., Biermann-Ruben K., Hummel F.C., et al. Altered intrahemispheric structural connectivity in Gilles de la Tourette syndrome. Neuroimage Clin 2014, 4:174-181.
12. Belluscio B.A., Jin L., Watters V., Lee T.H., Hallett M. Sensory sensitivity to external stimuli in Tourette syndrome patients. Mov Disord 2011, 26:2538-2543.
13. Shibasaki H., Hallett M. What is the Bereitschaftspotential?. Clin Neurophysiol 2006, 117:2341-2356.
14. Obeso J.A., Rothwell J.C., Marsden C.D. Simple tics in Gilles de la Tourette's syndrome are not prefaced by a normal premovement EEG potential. J Neurol Neurosurg Psychiatry 1981, 44:735-738.
15. Karp B.I., Porter S., Toro C., Hallett M. Simple motor tics may be preceded by a premotor potential. J Neurol Neurosurg Psychiatry 1996, 61:103-106.
16. van der Salm S.M., Tijssen M.A., Koelman J.H., van Rootselaar A.F. The bereitschaftspotential in jerky movement disorders. J Neurol Neurosurg Psychiatry 2012, 83:1162-1167.
17. Bohlhalter S., Goldfine A., Matteson S., Garraux G., Hanakawa T., Kansaku K., et al. Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain 2006, 129:2029-2037.
18. Lerner A., Bagic A., Boudreau E.A., Hanakawa T., Pagan F., Mari Z., et al. Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome. Neurology 2007, 68:1979-1987.
19. Lerner A., Bagic A., Hanakawa T., Boudreau E.A., Pagan F., Mari Z., et al. Involvement of insula and cingulate cortices in control and suppression of natural urges. Cereb Cortex 2009, 19:218-223.
20. Berman B.D., Horovitz S.G., Morel B., Hallett M. Neural correlates of blink suppression and the buildup of a natural bodily urge. Neuroimage 2012, 59:1441-1450.
21. Tinaz S., Belluscio B.A., Malone P., van der Veen J.W., Hallett M., Horovitz S.G. Role of the sensorimotor cortex in Tourette syndrome using multimodal imaging. Hum Brain Mapp 2014, 35:5834-5846.
22. Ziemann U., Paulus W., Rothenberger A. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry 1997, 154:1277-1284.
23. Castellanos F.X., Fine E.J., Kaysen D., Marsh W.L., Rapoport J.L., Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results. Biol Psychiatry 1996, 39:33-41.
24. Zebardast N., Crowley M.J., Bloch M.H., Mayes L.C., Wyk B.V., Leckman J.F., et al. Brain mechanisms for prepulse inhibition in adults with Tourette syndrome: initial findings. Psychiatry Res 2013, 214:33-41.
25. Kalanithi P.S., Zheng W., Kataoka Y., DiFiglia M., Grantz H., Saper C.B., et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci USA 2005, 102:13307-13312.
26. Lerner A., Bagic A., Simmons J.M., Mari Z., Bonne O., Xu B., et al. Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome. Brain 2012, 135:1926-1936.
27. Segawa M. Neurophysiology of Tourette's syndrome: pathophysiological considerations. Brain Dev 2003, 25:S62-S69.
28. Nomura Y., Segawa M. Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder: a hypothesis. Brain Dev 2003, 25:S37-S42.
29. Nomura Y., Fukuda H., Terao Y., Hikosaka O., Segawa M. Abnormalities of voluntary saccades in Gilles de la Tourette's syndrome: pathophysiological consideration. Brain Dev 2003, 25:S48-S54.
30. Graybiel A.M. Habits, rituals, and the evaluative brain. Annu Rev Neurosci 2008, 31:359-387.
31. Termine C., Selvini C., Rossi G., Balottin U. Emerging treatment strategies in Tourette syndrome: what's in the pipeline?. Int Rev Neurobiol 2013, 112:445-480.
32. Kurlan R.M. Treatment of Tourette syndrome. Neurotherapeutics 2014, 11:161-165.
33. Dutta N., Cavanna A.E. The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review. Funct Neurol 2013, 28:7-12.
34. Wile D.J., Pringsheim T.M. Behavior therapy for Tourette syndrome: a systematic review and meta-analysis. Curr Treat Options Neurol 2013, 15:385-395.
35. Shaw Z.A., Coffey B.J. Tics and Tourette syndrome. Psychiatr Clin North Am 2014, 37:269-286.
36. Hartmann A., Worbe Y. Pharmacological treatment of Gilles de la Tourette syndrome. Neurosci Biobehav Rev 2013, 37:1157-1161.
37. Egolf A., Coffey B.J. Current pharmacotherapeutic approaches for the treatment of Tourette syndrome. Drugs Today 2014, 50:159-179.
38. Chen J.J., Ondo W.G., Dashtipour K., Swope D.M. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther 2012, 34:1487-1504.
39. Muller-Vahl K.R. Treatment of Tourette syndrome with cannabinoids. Behav Neurol 2013, 27:119-124.
40. Muller-Vahl K.R. Surgical treatment of Tourette syndrome. Neurosci Biobehav Rev 2013, 37:1178-1185.
41. Kim W., Pouratian N. Deep brain stimulation for Tourette syndrome. Neurosurg Clin N Am 2014, 25:117-135.